Appeal No. 2002-0534 Page 7 Application No. 08/551,326 See the Examiner’s Answer, page 7. Thus, the examiner concludes, those of skill in the art would have found it obvious to replace the anabolic steroids discussed by Fahey with Monteleone’s phosphatidylserine, in order to inhibit cortisol levels without getting the dangerous side-effects of anabolic steroids. See the Examiner’s Answer, page 8. We do not agree that the combined disclosures of Fahey and Monteleone would have made it obvious to administer phosphatidylserine as a replacement of anabolic steroids, with a reasonable expectation of success. Monteleone teaches intravenous administration of phosphatidylserine, while the instant claims are directed to dietary supplements or methods comprising “ingesting” phosphatidylserine. Thus, the examiner’s position implicitly assumes that persons of skill in the art would have expected that the results seen by Monteleone’s intravenous administration of phosphatidylserine would also have been expected for oral administration. The examiner, however, has cited no evidence to indicate that those of skill in the art considered oral and intravenous administration of phosphatidylserine to be equivalents. In addition, the examiner has not adequately explained how the cited references would have made it obvious to combine phosphatidylserine with protein supplements, as required by, for example, claim 15. The examiner points to Fahey as disclosing the importance of “optimal protein intake” for athletes engaged in heavy training. Examiner’s Answer, page 6. The pages of Fahey cited by the examiner, however, are at best equivocal on the importance of protein supplements. Fahey states thatPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 NextLast modified: November 3, 2007